Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis.

Itoh, Naoya; Kawabata, Takanori; Akazawa, Nana; Kawamura, Daichi; Murakami, Hiromi; Ishibana, Yuichi; Kodama, Eiichi N; Ohmagari, Norio

Itoh, Naoya; Kawabata, Takanori; Akazawa, Nana; Kawamura, Daichi; Murakami, Hiromi; Ishibana, Yuichi; Kodama, Eiichi N; Ohmagari, Norio.

Affiliation

Itoh N; Collaborative Chairs Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
Kawabata T; Division of Infectious Diseases, Aichi Cancer Center Hospital, Nagoya, Japan.
Akazawa N; Department of Data Science, National Cerebral and Cardiovascular Center, Suita, Japan.
Kawamura D; Division of Infectious Diseases, Aichi Cancer Center Hospital, Nagoya, Japan.
Murakami H; Division of Infectious Diseases, Aichi Cancer Center Hospital, Nagoya, Japan.
Ishibana Y; Division of Infectious Diseases, Aichi Cancer Center Hospital, Nagoya, Japan.
Kodama EN; Division of Infectious Diseases, Aichi Cancer Center Hospital, Nagoya, Japan.
Ohmagari N; Division of Infectious Diseases, International Research Institute of Disaster Science, and Graduate School of Medicine, Tohoku University and Tohoku Medical Megabank Organization, Sendai, Japan.

PLoS One ; 18(2): e0281518, 2023.

Article de En | MEDLINE | ID: mdl-36758108

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anti-infectieux / Tumeurs Type d'étude: Guideline / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Japon Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google